We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+9.95%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$148B
AUM Growth
+$13.7B
Cap. Flow
+$2.5B
Cap. Flow %
1.69%
Top 10 Hldgs %
25.2%
Holding
4,104
New
267
Increased
1,933
Reduced
1,554
Closed
192

Sector Composition

Rank Sector Weight
1 Technology 16.03%
2 Financials 9.11%
3 Healthcare 8.03%
4 Industrials 6.97%
5 Consumer Discretionary 6.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DHR icon
76
Danaher
DHR
$145B
$335M 0.23%
1,343,260
+73,960
+6% +$18M
WMB icon
77
Williams Companies
WMB
$86.8B
$328M 0.22%
8,421,205
+55,248
+0.7% +$1.96M
SPGI icon
78
S&P Global
SPGI
$121B
$322M 0.22%
757,396
-1,151
-0.2% -$499K
VUG icon
79
Vanguard Morningstar Growth ETF
VUG
$230B
$322M 0.22%
5,614,200
-109,194
-2% -$6M
XLY icon
80
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.7B
$310M 0.21%
3,373,260
+93,762
+3% +$8.35M
ICE icon
81
Intercontinental Exchange
ICE
$85.2B
$310M 0.21%
2,253,168
+68,626
+3% +$9.11M
AMGN icon
82
Amgen
AMGN
$224B
$307M 0.21%
1,079,536
-74,674
-6% -$21.9M
TT icon
83
Trane Technologies
TT
$105B
$307M 0.21%
1,022,382
-13,906
-1% -$3.77M
RTX icon
84
RTX Corp
RTX
$303B
$304M 0.21%
3,115,524
+85,955
+3% +$7.76M
SDY icon
85
State Street SPDR S&P Dividend ETF
SDY
$22B
$302M 0.2%
2,301,496
-30,772
-1% -$3.86M
TMO icon
86
Thermo Fisher Scientific
TMO
$220B
$298M 0.2%
513,566
+43,660
+9% +$24.5M
INTU icon
87
Intuit
INTU
$90.8B
$296M 0.2%
455,881
+7,719
+2% +$4.93M
XLF icon
88
State Street Financial Select Sector SPDR ETF
XLF
$58.9B
$296M 0.2%
7,034,958
+3,962,574
+129% +$156M
TJX icon
89
TJX Companies
TJX
$177B
$294M 0.2%
2,897,533
+64,773
+2% +$6.28M
VPL icon
90
Vanguard FTSE Pacific ETF
VPL
$8.39B
$285M 0.19%
3,742,248
+121,641
+3% +$8.9M
DIS icon
91
Walt Disney
DIS
$178B
$284M 0.19%
2,323,652
+201,202
+9% +$21M
JCI icon
92
Johnson Controls International
JCI
$91.8B
$274M 0.19%
4,193,698
+429,919
+11% +$25M
TXN icon
93
Texas Instruments
TXN
$258B
$272M 0.18%
1,559,312
-119,431
-7% -$19.9M
LIN icon
94
Linde
LIN
$225B
$269M 0.18%
579,976
+12,102
+2% +$5.24M
KO icon
95
Coca-Cola
KO
$376B
$268M 0.18%
4,378,983
+92,068
+2% +$5.53M
ADBE icon
96
Adobe
ADBE
$108B
$263M 0.18%
520,552
-38,492
-7% -$22.1M
TGT icon
97
Target
TGT
$69.1B
$261M 0.18%
1,473,001
-2,046
-0.1% -$311K
IBM icon
98
IBM
IBM
$224B
$260M 0.18%
1,362,963
-2,376
-0.2% -$433K
MDLZ icon
99
Mondelez International
MDLZ
$78.5B
$253M 0.17%
3,620,094
+75,539
+2% +$5.51M
NOW icon
100
ServiceNow
NOW
$131B
$246M 0.17%
1,615,410
-41,620
-3% -$6.31M

Similar funds

Raymond James & Associates's Q1 2024 Portfolio in Review

As of Q1 2024, Raymond James & Associates held 4,104 positions worth $148B, up 10% from $134B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Raymond James & Associates's Q1 2024 filing shows 267 new, 1,933 increased, 1,554 reduced and 192 closed positions. Its largest new stake was Veralto: 431,115 shares worth $38.2M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $233M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q1 2024 buy was Veralto: 431,115 shares worth $38.2M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q1 2024, an estimated $292M increase.
  • Raymond James & Associates's biggest Q1 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $233M.
  • Raymond James & Associates fully exited Splunk Inc in Q1 2024, selling an estimated $14.6M.
  • Raymond James & Associates's ten largest holdings make up 25% of its $148B portfolio in Q1 2024.
  • Raymond James & Associates opened 267 new positions and closed 192 in Q1 2024.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $148B.

Based on Raymond James & Associates's 13F filing for Q1 2024, filed 22 Apr 2024.